Brief: Evolus Sees FY sales USD 180-190 million
09/05/2023 22:12
May 9 (Reuters) - Evolus Outlook FY sales USD 180-190 million. * Outlook FY sales growth 21-28% * Q1 adjusted gross margin 70.9% * Q1 gross profit USD 28.836 million * Q1 gross margin 69.1% * Q1 net income USD -14.791 million * Q1 EPS USD -0.26
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe